Showing results (261-270 of 278) with videos related to

Sort By:
Pageof 28
Scientific Reports|November 7, 2023
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcomaEashwar Somasundaram, Peter M Anderson, Timothy D Smile, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Managing a Large-Scale Multiomics Project: A Team Science Case Study in ProteogenomicsPaul A Stewart, Eric A Welsh, Bin Fang, et al.
European Urology|December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate CancerKosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.
Cancer|April 21, 2012
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderJacob G Scott, Luc Bauchet, Tyler J Fraum, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution ExperienceDaniel E Oliver, Jose M Laborde, Deepinder P Singh, et al.
European Urology|April 23, 2025
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Patrick J Hensley, Roger Li, et al.
European Urology Oncology|November 17, 2020
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile CarcinomaMarco Bandini, Jeffrey S Ross, Yao Zhu, et al.
Nature Communications|August 10, 2019
Proteogenomic landscape of squamous cell lung cancerPaul A Stewart, Eric A Welsh, Robbert J C Slebos, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Optimal Timing of Organs-at-Risk-Sparing Adaptive Radiation Therapy for Head- and-Neck Cancer under Re-planning Resource ConstraintsFatemeh Nosrat, Cem Dede, Lucas B McCullum, et al.
Pageof 28